Nurix Therapeutics (NRIX) Cash & Current Investments (2019 - 2026)
Nurix Therapeutics' Cash & Current Investments came in at $1.05 billion for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 144.4% from $428.83 million a year earlier and up 136.3% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Cash & Current Investments was $592.94 million, down 2.7% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
- Going back by fiscal year, Cash & Current Investments was $609.58 million in FY2024 (+111.7%), $287.91 million in FY2023 (-6.9%), $309.14 million in FY2022 (+4.5%) and $295.7 million in FY2021 (+5.2%).
- The fiscal Q3 2026 figure represents the highest quarterly Cash & Current Investments in data going back to fiscal Q3 2019.
- Year-over-year, Cash & Current Investments increased in three of the last seven quarters, with growth averaging 35.5%.
- The fastest year-over-year change in Cash & Current Investments over five years came in fiscal Q3 2026 (growth of 144.4%), and the weakest in fiscal Q1 2024 (a decline of 82.0%).
- Business Quant data shows NRIX's Cash & Current Investments at $443.53 million (Q2 2026), $540.73 million (Q1 2026) and $592.94 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 1.05 Bn |
| May 31, 2026 | 443.53 Mn |
| Feb 28, 2026 | 540.73 Mn |
| Nov 30, 2025 | 592.94 Mn |
| Aug 31, 2025 | 428.83 Mn |
| May 31, 2025 | 485.78 Mn |
| Feb 28, 2025 | 549.68 Mn |
| Nov 30, 2024 | 609.58 Mn |
| Aug 31, 2024 | 448.05 Mn |
| May 31, 2024 | 443.14 Mn |
| Feb 29, 2024 | 243.99 Mn |
| Nov 30, 2023 | 287.91 Mn |
| Aug 31, 2023 | 258.85 Mn |
| May 31, 2023 | 281.18 Mn |
| Feb 28, 2023 | 277.15 Mn |
| Nov 30, 2022 | 309.14 Mn |
| Aug 31, 2022 | 344.48 Mn |
| May 31, 2022 | 297.28 Mn |
| Feb 28, 2022 | 261.98 Mn |
| Nov 30, 2021 | 295.70 Mn |
API Access
Nurix Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();